COVID-19 / Coronavirus
LifeTech Scientific Corporation Announces 2021 Interim Results
SHENZHEN, China, Aug. 31, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with...
Viva Biotech Announced 2021 Interim Results
Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded a Significant Increase of 72% Financial Highlights for the 6 months ended June 30, 2021: * Revenue amounted to RMB1,026.5 million, representing a year-on-year (YoY) increase of approximately 419...
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix
SEOUL, South Korea, Aug. 30, 2021 /PRNewswire/ -- CancerRop (180400), a company specializing in precision medicine and molecular diagnostics, announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonucleic acid) with Hanmi Science through20 billion won worth of investmen...
Endurance RP Limited (Stock Code: 0575.HK) Announces 2021 Interim Results
HONG KONG, Aug. 30, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), aHong Kong-based investment company specializing in growth and value-led investments in the healthcare and late-stage life s...
Alphamab Oncology Reports 2021 Interim Results and Business Highlights
SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK), announced the company's interim results for the six months ended on June 30, 2021, and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2021 ...
REPASSA Embraces Enterprise Mobility to make their Business Operations Seamless across their Southeast Asia Operations with HokuApps
SINGAPORE, Aug. 27, 2021 /PRNewswire/ -- For simplifying the order processing
of the customized products,REPASSA
Modern Chinese Medicine Announces Year 2021 Interim Results
PERFORMANCE HIGHLIGHTS * Revenue increased by 8.8% to RMB171.8 million * Gross profit increased by 10.4% to RMB78.6 million * Profit after tax increased by 10.5% to approximately RMB44.1 million * The increase in revenue was primarily driven by the surge in revenue generated from the sales...
Fuwei Films Announces Results of Extraordinary General Meeting in 2021
BEIJING, Aug. 26, 2021 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (Nasdaq: FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films inChina, today announced that an Extraordinary General Meeting of Shareholders (the "EGM") was held today, at...
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
Genomics England Announces Appointment Of New Chief Scientific Officer
LONDON, Aug. 26, 2021 /PRNewswire/ -- Genomics England today announces the
appointment of Professor Matt Brown as the organisation's new Chief Scientific
Officer following a rigorous recruitment process.
ASEAN-focused dental group, Oracare Group, formed with plans to accelerate expansion across Southeast Asia
SINGAPORE, Aug. 26, 2021 /PRNewswire/ -- Singapore based Oracare Group ("Oracare"), one of the largest dental groups inSoutheast Asia, is the new holding company and international brand for a collection of successful national dental groups. Already present in 3 SE Asian countries, the group has a...
Seattle Co Develops Rapid Fingerprinting For Covid-19 Variants
First-Ever Technology Receives NIH Grant to Speed Up Availability of Testing SEATTLE, Aug. 26, 2021 /PRNewswire/ -- ID Genomics (IDG), a Seattle -based company, has invented a dipstick-based, rapid test for simultaneous identification of a large number of genetic variants of SARS-CoV-2 and has jus...
XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos
BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...
Accedian recognized as "Value Leader" in EMA's 2021 Network Performance Management Radar Report
MONTREAL, Aug. 25, 2021 /PRNewswire/ -- Accedian, a leader in performance analytics and end user experience solutions, is thrilled to have been recognized as a "Value Leader" by Enterprise Management Associates (EMA) in their2021 Radar Report: Network Performance Management (NPM). The needs of e...
Report from the Annual General Meeting 2021 in Elekta
STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A statement from the CEO and P...
Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia
SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that it has entered into a licensing agreement with PT Etana Biotechnol...
Senhwa Biosciences Announces Dose Escalation Initiation of the Phase I Trial of Pidnarulex as a Treatment for Advanced Hematological Malignancies
TAIPEI and SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced the initiation of Dose Escalation within the Phase I Investigator Init...
Halfway into 2021, Ping An Good Doctor winning trust of over 400 million registered users in China
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- As China recovers from the 2020 COVID-19 pandemic, online healthcare is playing a key role in ensuring a healthy and robust future for individuals, companies and communities.Ping An Good Doctor (1833.HK), a leading online medical and healthcare service pla...
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients
DURHAM, N.C. and BEIJING, Aug. 25, 2021 /PRNewswire/ -- Brii Biosciences
Ping An Good Doctor posts 39% revenue growth in the first half of 2021; Revenue from medical services grows 50.6%; Total number of registered users reaches 400 million
HONG KONG and SHANGHAI, Aug. 24, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 01833.HK), a leading online medical and healthcare service platform in China, has announced its 2021 interim results. During the reporting period, the Compan...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 251 media titles]
2024-04-30 15:13Most Read
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
